BioSpace News Archive

Policy

J&J Close to Reaching $4 Billion Agreement to Settle Thousands of Opioid Lawsuits, Sources Say

Citing “sources familiar with the matter,” The Wall Street Journal reported that the agreement, should it be reached, would ultimately settle the matter for the company related to sales of Duragesic and Nucynta.

October 17, 2019
·
2 min read
·
Alex Keown
After Snapping up Ra Pharma, UCB Hits the Mark in Psoriasis Trial

With 16 weeks of treatment, bimekizumab-treated patients saw a 90% improvement based on clinical assessment scales.

October 17, 2019
·
2 min read
·
Alex Keown
Career Advice

Mastering the Case Job Interview: A Guide for Life Sciences Professionals

Case job interviews are aimed at gauging at least some of the skills used in a consulting practice.

October 17, 2019
·
4 min read
·
Katharine Hansen, PhD
Drug Development

Navire Pharma, a BridgeBio subsidiary, to Present Data Showing Potential of SHP2 Inhibitor IACS-13909 in Treatment-Resistant Lung Cancer

Preclinical data shows SHP2 inhibitor enhances activity of osimertinib in EGFR-driven tumor xenografts

October 17, 2019
·
2 min read
Biotech Beach

Bionano Genomics Announces Adoption of Its Saphyr® System by Clinical Cytogenetics Groups in Academia and Industry to Replace Traditional Methods for Clinical Testing

Successful validation of Saphyr to replace “gold standard” method of southern blotting for molecular diagnosis of FSHD supports broad utility of Saphyr

October 17, 2019
·
6 min read
Finalists revealed for CPhI Worldwide’s eagerly anticipated 2019 Awards

CPhI Worldwide announces the finalists for the CPhI Pharma Awards.

October 17, 2019
·
3 min read
Business

BioSpace Movers & Shakers, Oct. 18

Pharma, biotech and medtech companies strengthen their executive ranks and boards with this week’s Movers & Shakers.

October 17, 2019
·
5 min read
·
Alex Keown
Regenstrief leaders to deliver keynote addresses at health data workshop in South America

Two of Regenstrief Institute’s leaders are sharing their expertise in artificial intelligence and data infrastructure at a workshop hosted by Brazil’s National Institute of Science and Technology in Scientific Assisted Medicine in Sao Paulo, Brazil.

October 17, 2019
·
1 min read
Policy

Minoryx Therapeutics receives FDA Orphan Drug Designation for leriglitazone in Friedreich’s Ataxia

Minoryx Therapeutics announces that its lead drug candidate, leriglitazone (MIN-102), has been granted Orphan Drug Designation in Friedreich’s Ataxia by the US Food and Drug Administration (FDA).

October 17, 2019
·
4 min read
Aalto Bio Reagents Launches World’s First Commercially Available Venezuela Equine Encephalitis Virus (VEEV) Protein

On the occasion of the first market partnership for Japan Aalto Bio Reagents launches the first commercially available protein for the detection and diagnosis of Venezuela Equine Encephalitis NSP2 TC83.

October 17, 2019
·
4 min read